The latest National Family Health Survey reveals a rise in adult obesity, driven by urbanization, poor dietary habits and ...

New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes ...

A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...

Objectives Despite adherence to guideline-based pharmacotherapy, many people with diabetic kidney disease (DKD) were unable to meet glycaemic and blood pressure targets. The purpose of this paper was ...

For patients who want a closer look at metabolic risk, several specialized tests go beyond standard glucose measurements.

Introduction Diabetes mellitus is a highly prevalent metabolic disorder associated with chronic, low-grade inflammation. Of recent interest is the association between diabetes and circadian rhythm ...

Red meat has gotten a bad reputation. But do you really need to limit it? Here’s what the experts and research say.

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it will present data from clinical studies of sotagliflozin in Type 1 diabetes (T1D) and pilavapadin in diabetic peripheral ...

Novo Nordisk is rated a strong buy, offering a 4.2% yield and trading at a 40% discount to fair value. Click here to read ...

FibroBiologics is conducting a prospective, multicenter, randomized clinical trial evaluating the safety, tolerability, and efficacy of CYWC628 in treating refractory diabetic foot ulcers with up to ...

Research presented at the American Society of Clinical Oncology meeting suggests that popular GLP-1 weight loss and diabetes drugs may lower cancer risks and improve treatment outcomes in patients.